Type I interferons inhibit the generation of tumor-associated macrophages

Cancer Immunology, Immunotherapy

Volumn 59, Issue 4, 2010, Pages 587-598

  U'Ren, Lance ^a   Guth, Amanda ^a   Kamstock, Debra ^a   Dow, Steven ^a  

^a Department of Ecosystem Science and Sustainability   (United States)

Author keywords

Angiogenesis; Cancer; CSF 1; Cytokine

Indexed keywords

COLONY STIMULATING FACTOR 1; INTERFERON; INTERFERON RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; CYTOKINE; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CANCER INHIBITION; CELL DENSITY; CONTROLLED STUDY; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH; TUMOR VASCULARIZATION; ANIMAL; CELL MOTION; DRUG EFFECT; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL NEOPLASM; FEMALE; GENETICS; MACROPHAGE; MALE; METABOLISM; MOUSE MUTANT; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULARIZATION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL MOVEMENT; CHEMOKINE CCL2; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; IMMUNOENZYME TECHNIQUES; INTERFERON TYPE I; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES; MALE; MICE; MICE, KNOCKOUT; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 77449089079     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-009-0776-6     Document Type: Article

References (55)

1. vonMarschallZ,ScholzA,CramerT,SchaferG,SchirnerM,ObergK,WiedenmannB, HockerM,RosewiczS(2003) Effectsofinterferonalphaonvascularendothelialgrowthfactorgenetranscriptionan dtumorangiogenesis.JNatlCancerInst95:437-448(Pubitemid36432418)
2. Gutterman JU (1994) Cytokine therapeutics: lessons from interferon alpha. Proc Natl Acad Sci USA 91:1198-1205
3. Oberg K (2000) Interferon in the management of neuroendocrine GEP-tumors: a review. Digestion 62(Suppl 1):92-97
4. Gaudin PB, Rosai J (1995) Florid vascular proliferation associated with neural and neuroendocrine neoplasms. A diagnostic clue and potential pitfall. Am J Surg Pathol 19:642-652
5. AlbiniA,MarchisoneC,DelGrossoF,BenelliR,MasielloL,TacchettiC,BonoM, FerrantiniM,RozeraC,TruiniM,BelardelliF,SantiL,NoonanDM(2000) Inhibitionofangiogenesisandvasculartumorgrowthbyinterferon-producingcells: Agenetherapyapproach.AmJPathol156:1381-1393(Pubitemid30660014)
6. SgoncR,FuerhapterC,BoeckG,SwerlickR,FritschP,SeppN(1998) Inductionofapoptosisinhumandermalmicrovascularendothelialcellsandinfantileheman giomasbyinterferon-alpha.IntArchAllergyImmunol117:209-214(Pubitemid28526169)
7. Singh RK, Gutman M, Bucana CD, Sanchez R, Llansa N, Fidler IJ (1995) Interferons alpha and beta down-regulate the expression of basic fibroblast growth factor in human carcinomas. Proc Natl Acad Sci USA 92:4562-4566
8. Oliveira IC, Sciavolino PJ, Lee TH, Vilcek J (1992) Downregulation of interleukin 8 gene expression in human fibroblasts: unique mechanism of transcriptional inhibition by interferon. Proc Natl Acad Sci USA 89:9049-9053
9. McCarty MF, Bielenberg D, Donawho C, Bucana CD, Fidler IJ (2002) Evidence for the causal role of endogenous interferonalpha/beta in the regulation of angiogenesis, tumorigenicity, and metastasis of cutaneous neoplasms. Clin Exp Metastasis 19:609-615 (Pubitemid 35454571)
10. Dunn GP, Bruce AT, Sheehan KC, Shankaran V, Uppaluri R, Bui JD, Diamond MS, Koebel CM, Arthur C, White JM, Schreiber RD (2005) A critical function for type I interferons in cancer immunoediting. Nat Immunol 6:722-729 (Pubitemid 41716746)
11. Pollard JW (2004) Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 4:71-78
12. Lewis CE, Pollard JW (2006) Distinct role of macrophages in different tumor microenvironments. Cancer Res 66:605-612 (Pubitemid 43165918)
13. Tsutsui S, Yasuda K, Suzuki K, Tahara K, Higashi H, Era S (2005) Macrophage infiltration and its prognostic implications in breast cancer: the relationship with VEGF expression and microvessel density. Oncol Rep 14:425-431
14. Lissbrant IF, Stattin P, Wikstrom P, Damber JE, Egevad L, Bergh A (2000) Tumor associated macrophages in human prostate cancer: relation to clinicopathological variables and survival. Int J Oncol 17:445-451
15. Leek RD, Landers RJ, Harris AL, Lewis CE (1999) Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast. Br J Cancer 79:991-995
16. Lin EY, Nguyen AV, Russell RG, Pollard JW (2001) Colonystimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 193:727-740
17. Gazzaniga S, Bravo AI, Guglielmotti A, van Rooijen N, Maschi F, Vecchi A, Mantovani A, Mordoh J, Wainstok R (2007) Targeting tumor-associated macrophages and inhibition of CCL2 reduce angiogenesis and tumor growth in a human melanoma xenograft. J Invest Dermatol 127:2031-2041 (Pubitemid 47075380)
18. Zeisberger SM, Odermatt B, Marty C, Zehnder-Fjallman AH, Ballmer-Hofer K, Schwendener RA (2006) Clodronate-liposomemediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach. Br J Cancer 95:272-281 (Pubitemid 44187587)
19. Murdoch C, Lewis CE (2005) Macrophage migration and gene expression in response to tumor hypoxia. Int J Cancer 117:701-708 (Pubitemid 41598819)
20. Pugh CW, Ratcliffe PJ (2003) Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med 9:677-684 (Pubitemid 36749216)
21. Mantovani A, Allavena P, Sozzani S, Vecchi A, Locati M, Sica A (2004) Chemokines in the recruitment and shaping of the leukocyte infiltrate of tumors. Semin Cancer Biol 14:155-160 (Pubitemid 38586740)
22. Balkwill F (2004) Cancer and the chemokine network. Nat Rev Cancer 4:540-550
23. Stanley ER, Guilbert LJ, Tushinski RJ, Bartelmez SH (1983) CSF1-a mononuclear phagocyte lineage-specific hemopoietic growth factor. J Cell Biochem. 21:151-159
24. SchollSM,PalludC,BeuvonF,HaceneK,StanleyER,RohrschneiderL,TangR, PouillartP,LidereauR(1994)Anticolony-stimulatingfactor- 1antibodystaininginprimarybreastadenocarcinomascorrelateswithmarkedinflammatory cellinfiltratesandprognosis.JNatlCancerInst86:120-126(Pubitemid24040150)
25. Hamilton JA, Whitty GA, Kola I, Hertzog PJ (1996) Endogenous IFN-alpha beta suppresses colony-stimulating factor (CSF)-1stimulated macrophage DNA synthesis and mediates inhibitory effects of lipopolysaccharide and TNF-alpha. J Immunol 156:2553-2557
26. Moore RN, Larsen HS, Horohov DW, Rouse BT (1984) Endogenous regulation of macrophage proliferative expansion by colonystimulating factor-induced interferon. Science 223:178-181
27. Kamstock D, Guth A, Elmslie R, Kurzman I, Liggitt D, Coro L, Fairman J, Dow S (2006) Liposome-DNA complexes infused intravenously inhibit tumor angiogenesis and elicit antitumor activity in dogs with soft tissue sarcoma. Cancer Gene Ther 13:306-317 (Pubitemid 43255768)
28. Sellins K, Fradkin L, Liggitt D, Dow S (2005) Type I interferons potently suppress gene expression following gene delivery using liposome(-)DNA complexes. Mol Ther 12:451-459 (Pubitemid 41150130)
29. DoughtyL,NguyenK,DurbinJ,BironC(2001)AroleforIFN- alphabetainvirusinfection-inducedsensitization-endotoxin.JImmunol166: 2658-2664(Pubitemid32173505)
30. Yang LV, Radu CG, Wang L, Riedinger M, Witte ON (2005) Gi-independent macrophage Chemotaxis to lysophosphatidylcholine via the immunoregulatory GPCR G2A. Blood 105:1127-1134 (Pubitemid 40170885)
31. Fadok VA, de Cathelineau A, Daleke DL, Henson PM, Bratton DL (2001) Loss of phospholipid asymmetry and surface exposure of phosphatidylserine is required for phagocytosis of apoptotic cells by macrophages and fibroblasts. J Biol Chem 276:1071-1077
32. FadokVA,SavillJS,HaslettC,BrattonDL,DohertyDE,CampbellPA,HensonPM(1992) Differentpopulationsofmacrophagesuseeitherthevitronectinreceptororthephosphati dylserinereceptor-recognizeandremoveapoptoticcells.JImmunol149: 4029-4035(Pubitemid23068888)
33. Hansen MB, Nielsen SE, Berg K (1989) Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods 119:203-210
34. Ball HJ, MacDougall HG, McGregor IS, Hunt NH (2004) Cyclooxygenase-2 in the pathogenesis of murine cerebral malaria. J Infect Dis 189:751-758
35. Kubota Y, Ito K (2000) Chemotactic migration of mesencephalic neural crest cells in the mouse. Dev Dyn 217:170-179 (Pubitemid 30080496)
36. Giraudo E, Inoue M, Hanahan D (2004) An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis. J Clin Invest 114:623-633 (Pubitemid 39578752)
37. Kirma N, Luthra R, Jones J, Liu YG, Nair HB, Mandava U, Tekmal RR (2004) Overexpression of the colony-stimulating factor (CSF-1) and/or its receptor c-fms in mammary glands of transgenic mice results in hyperplasia and tumor formation. Cancer Res 64:4162-4170 (Pubitemid 38802419)
38. Meissner A, Zilles O, Varona R, Jozefowski K, Ritter U, Marquez G, Hallmann R, Korner H (2003) CC chemokine ligand 20 partially controls adhesion of naive B cells to activated endothelial cells under shear stress. Blood 102:2724-2727 (Pubitemid 37248838)
39. Chen X, Aravindakshan J, Yang Y, Tiwari-Pandey R, Sairam MR (2006) Aberrant expression of PDGF ligands and receptors in the tumor prone ovary of follitropin receptor knockout (FORKO) mouse. Carcinogenesis 27:903-915
40. Lardot C, Delos M, Lison D (1998) Upregulation of urokinase in alveolar macrophages and lung tissue in response to silica particles. Am J Physiol 274:L1040-L1048
41. Kirkwood JM, Strawderman MH, Ernstoff MS, Smith TJ, Borden EC, Blum RH (1996) Interferon alfa-2b adjuvant therapy of highrisk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol 14:7-17
42. Avnet S, Cenni E, Perut F, Granchi D, Brandi ML, Giunti A, Baldini N (2007) Interferon-alpha inhibits in vitro osteoclast differentiation and renal cell carcinoma-induced angiogenesis. Int J Oncol 30:469-476
43. GuttermanJU,BlumenscheinGR,AlexanianR,YapHY,BuzdarAU,CabanillasF, HortobagyiGN,HershEM,RasmussenSL,HarmonM,KramerM,PestkaS(1980) Leukocyteinterferoninducedtumorregressioninhumanmetastaticbreastcancer, multiplemyeloma,andmalignantlymphoma.AnnInternMed93:399-406(Pubitemid10055897)
44. Serafini P, Borrello I, Bronte V (2006) Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression. Semin Cancer Biol 16:53-65 (Pubitemid 43139709)
45. Nagaraj S, Gabrilovich DI (2007) Myeloid-derived suppressor cells. Adv Exp Med Biol 601:213-223
46. Serbina NV, Pamer EG (2006) Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat Immunol 7:311-317
47. Serbina NV, Jia T, Hohl TM, Pamer EG (2008) Monocyte-mediated defense against microbial pathogens. Annu Rev Immunol 26:421-452 (Pubitemid 351600381)
48. Wyckoff J, Wang W, Lin EY, Wang Y, Pixley F, Stanley ER, Graf T, Pollard JW, Segall J, Condeelis J (2004) A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res 64:7022-7029 (Pubitemid 39331012)
49. Lin EY, Gouon-Evans V, Nguyen AV, Pollard JW (2002) The macrophage growth factor CSF-I in mammary gland development and tumor progression. J Mammary Gland Biol Neoplasia 7:147-162 (Pubitemid 38420772)
50. Bouma G, Nikolic T, Coppens JM, van Helden-Meeuwsen CG, Leenen PJ, Drexhage HA, Sozzani S, Versnel MA (2005) NOD mice have a severely impaired ability to recruit leukocytes into sites of inflammation. Eur J Immunol 35:225-235 (Pubitemid 40123869)
51. Burke B, Tang N, Corke KP, Tazzyman D, Ameri K, Wells M, Lewis CE (2002) Expression of HIF-1 alpha by human macrophages: implications for the use of macrophages in hypoxiaregulated cancer gene therapy. J Pathol 196:204-212 (Pubitemid 34110902)
52. Lin EY, Li JF, Gnatovskiy L, Deng Y, Zhu L, Grzesik DA, Qian H, Xue XN, Pollard JW (2006) Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res 66:11238-11246 (Pubitemid 46009952)
53. Wiktor-Jedrzejczak W, Ratajczak MZ, Ptasznik A, Sell KW, Ahmed-Ansari A, Ostertag W (1992) CSF-1 deficiency in the op/ op mouse has differential effects on macrophage populations and differentiation stages. Exp Hematol 20:1004-1010
54. Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD (1998) How cells respond to interferons. Annu Rev Biochem 67:227-264
55. Dolcetti L, Marigo I, Mantelli B, Peranzoni E, Zanovello P, Bronte V (2008) Myeloid-derived suppressor cell role in tumor-related inflammation. Cancer Lett 267:216-225